AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached ...

The Prognostic Nutritional Index and systemic oxidative stress score are independently associated with poorer prognosis of low-risk MDS.

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.

The rise of long-term opioid therapy for chronic noncancer pain between 2013 and 2022 despite its limited effectiveness highlights the need for revised primary care pain guidelines. Between 2013 and ...

The prevalence of frailty was 33% among a US-wide cohort of patients with RMDs, with the highest rates found among those with fibromyalgia or CTDs.

Pain and opioid use were reduced in patients with advanced knee OA following ultrasound-guided chemical neurolysis of 4 genicular nerves.

From 2010 to 2023, physician exit rates from traditional Medicare increased, according to study findings published in JAMA Health Forum.

Alopecia areata has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity.

Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.

Bedtime TNX-102 SL was safe and effective for the treatment of fibromyalgia by improving symptoms of pain, disrupted sleep, and fatigue.

Cannabis use disorder is associated with increased risk of benign salivary gland tumors, according to study findings.

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.